CVC Highlight: Clearing it all up: A review of new dermatology drugs - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

CVC Highlight: Clearing it all up: A review of new dermatology drugs
Are you aware of the front-line treatments dermatologists are using and investigating?


VETERINARY MEDICINE


REFERENCES

1. Hensel P, Austel M, Wooley RE, et al. In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs. Vet Dermatol 2009;20(5):429-434.

2. Wooley RE, Ritchie BW, Burnley VV. In vitro effect of a buffered chelating agent and neomycin or oxytetracycline on bacteria associated with diseases of fish. Dis Aquat Organ 2004;59(3):263-267.

3. Weinstein WL, Moore PA, Sanchez S, et al. In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis. Am J Vet Res 2006;67(4):562-568.

4. Austel M, Hensel P, Wooley RE, et al. Comparison of the effect of tris EDTA (Tricide)-ciprofloxacin-fluconazole-dexamethasone-ear drops with Baytril otic in dogs with acute or chronic bacterial otitis externa (abstr). Vet Dermatol 2009;20: 218.

5. Vaden SL. Cyclosoprine and tacrolimus. Semin Vet Med Surg (Small Anim Pract) 1997; 12(3):161-166.

6. Griffies JD, Mendelsohn CL, Rosenkrantz WS, et al. Topical 0.1% tacrolimus for the treatment of discoid lupus erythematosus and pemphigus erythematosus in dogs. J Am Anim Hosp Assoc 2004;40(1):29-41.

7. Wisselink MA, Willemse T. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomized prednisolone-controlled study. Vet J 2009;180(1):55-59.

8. Rees CA, Boothe DM. Therapeutic response to pentoxifylline and its active metabolites in dogs with familial canine dermatomyositis. Vet Ther 2003;4(3):234-241.

9. Cerundolo R, Lloyd DH, Persechino A, et al. Treatment of canine Alopecia X with trilostane. Vet Dermatol 2004;15(5):285-293.

10. Cadot P, Hensel P, Bensignor E, et al. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial. Vet Dermatol 2011;22(6):554-564.

11. Thompson LA, Grieshaber TL, Glickman L, et al. Human recombinant interferon alpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study. Vet Ther 2004;5(1):75-81.


ADVERTISEMENT

Source: VETERINARY MEDICINE,
Click here